Nakanishi Ryota, Ishida Mitsuaki, Hodohara Keiko, Yoshida Takashi, Yoshii Miyuki, Okuno Hiroko, Horinouchi Akiko, Iwai Muneo, Yoshida Keiko, Kagotani Akiko, Okabe Hidetoshi
Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.
Int J Clin Exp Pathol. 2013 Jul 15;6(8):1677-82. Print 2013.
Gelatinous bone marrow transformation (GMT) is a rare disorder characterized by the presence of fat cell atrophy, loss of hematopoietic cells, and deposition of extracellular gelatinous materials. GMT is not a specific disease, but is strongly associated with malnutrition and drugs. Albeit extremely rare, GMT has been reported in patients with myeloproliferative disorders. Herein, we report the second documented case of hypoplastic myelodysplastic syndrome (MDS) accompanying GMT. A 73-year-old Japanese male with excellent nutrition status and no history of alcohol or drug intake was detected with pancytopenia. The initial bone marrow aspirate specimen reveled hypocellular marrow without dysplastic signs in the myeloid cells. Bone marrow biopsy demonstrated hypocellular bone marrow with prominent GMT. He received blood transfusions, however, pancytopenia continued to progress. The second bone marrow aspirate specimen showed dysplastic changes, such as pseudo-Pelger-Huët cells, hypogranular or agranular granulocytes, and megakaryocytes with multiple small nuclei. Cytogenetic study demonstrated deletion of chromosome 7. Therefore, an ultimate diagnosis of hypoplastic MDS accompanying GMT was made. Only a limited number of cases of myeloproliferative disorders with GMT have been reported. Our analysis of these cases revealed that chromosome 7 abnormality is frequently observed in this condition. Moreover, findings from the current case suggested that myeloproliferative disorders including MDS must be included in the differential diagnostic considerations of GMT patients, who have no history of malnutrition or drugs, and careful examination of the bone marrow smear specimen and cytogenetic analysis are necessary for early detection of underlying myeloproliferative disorders.
胶冻样骨髓转化(GMT)是一种罕见的疾病,其特征为脂肪细胞萎缩、造血细胞缺失以及细胞外胶冻样物质沉积。GMT并非一种特定疾病,但与营养不良和药物密切相关。尽管极为罕见,但GMT已在骨髓增殖性疾病患者中被报道。在此,我们报告第二例伴有GMT的低增生性骨髓增生异常综合征(MDS)病例。一名73岁营养状况良好、无饮酒或用药史的日本男性被检测出全血细胞减少。最初的骨髓穿刺标本显示骨髓细胞减少,髓系细胞无发育异常迹象。骨髓活检显示骨髓细胞减少,伴有明显的GMT。他接受了输血治疗,然而全血细胞减少仍持续进展。第二次骨髓穿刺标本显示出发育异常改变,如假佩尔格-许埃特细胞、颗粒减少或无颗粒的粒细胞以及具有多个小核的巨核细胞。细胞遗传学研究显示7号染色体缺失。因此,最终诊断为伴有GMT的低增生性MDS。仅有少数伴有GMT的骨髓增殖性疾病病例被报道。我们对这些病例的分析显示,在此情况下经常观察到7号染色体异常。此外,当前病例的结果表明,对于无营养不良或用药史的GMT患者,鉴别诊断时必须考虑包括MDS在内的骨髓增殖性疾病,并且仔细检查骨髓涂片标本和进行细胞遗传学分析对于早期发现潜在的骨髓增殖性疾病是必要的。